Association between polycystic ovary syndrome and hot flash presentation during the midlife period

Objective: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in reproductive-aged women; however, the impact of PCOS on menopausal symptoms remains poorly understood. This study aims to determine the influence of PCOS on hot flash presentation in midlife women. Methods: Participants were recruited from the Midlife Women's Health Study involving 780 women aged 45 to 54 years. All women completed detailed questionnaires on hot flash symptoms. Between June 2014 and March 2015, participants were screened for history of PCOS based on the Rotterdam criteria. Fisher's exact tests and Wilcoxon rank-sum tests were used for analysis. Multivariate logistic regression was performed to identify factors associated with hot flashes at midlife. Results: In all, 453 women (69%) consented to the telephone interview and 9.3% (n = 42) met diagnostic criteria for PCOS; 411 were included as controls. Mean age was 48.0 and body mass index was 27.3 for women with PCOS. The majority of participants were white (72%). There was no difference between PCOS and control women for levels of follicle-stimulating hormone, testosterone, progesterone, or estradiol. Multivariate logistic regression demonstrated that PCOS was not associated with increased odds of hot flash incidence. Smoking was the only variable associated with experiencing hot flashes (odds ratio 2.0, 95% confidence interval 1.05-3.98). Conclusions: A history of PCOS was not associated with increased hot flash symptoms during the midlife period. Additional research should continue to investigate the health and quality of life associated with a history of PCOS in the aging population.

[1]  J. Flaws,et al.  The Midlife Women’s Health Study – a study protocol of a longitudinal prospective study on predictors of menopausal hot flashes , 2017, Women's Midlife Health.

[2]  A. Ruokonen,et al.  Androgen Profile Through Life in Women With Polycystic Ovary Syndrome: A Nordic Multicenter Collaboration Study. , 2015, The Journal of clinical endocrinology and metabolism.

[3]  P. Sluss,et al.  Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging , 2012, Menopause.

[4]  M. Brännström,et al.  Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. , 2011, The Journal of clinical endocrinology and metabolism.

[5]  A. Ruokonen,et al.  Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS. , 2011, The Journal of clinical endocrinology and metabolism.

[6]  S. Carranza-Lira.  Actual status of veralipride use , 2010, Clinical interventions in aging.

[7]  F. Petraglia,et al.  Reduction of serum serotonin precursors after veralipride treatment for postmenopausal hot flushes , 2010, Climacteric : the journal of the International Menopause Society.

[8]  M. Olovsson,et al.  Long-term follow-up of patients with polycystic ovary syndrome: reproductive outcome and ovarian reserve. , 2009, Human reproduction.

[9]  A. Ruokonen,et al.  Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. , 2009, The Journal of clinical endocrinology and metabolism.

[10]  J. Flaws,et al.  Cigarette Smoking, Androgen Levels, and Hot Flushes in Midlife Women , 2008, Obstetrics and gynecology.

[11]  Ellen W Freeman,et al.  Symptoms Associated With Menopausal Transition and Reproductive Hormones in Midlife Women , 2007, Obstetrics and gynecology.

[12]  J. Flaws,et al.  Cigarette smoking, estrogen levels, and hot flashes in midlife women. , 2006, Maturitas.

[13]  L. Dennerstein,et al.  The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project , 2004, Climacteric : the journal of the International Menopause Society.

[14]  K. Matthews,et al.  The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  Ricardo Azziz,et al.  0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2745–2749 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2003-032046 The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected , 2022 .

[16]  J. Flaws,et al.  Risk factors for hot flashes in midlife women. , 2003, Journal of women's health.

[17]  J. Schoemaker,et al.  Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. , 2003, Fertility and sterility.

[18]  P. Langenberg,et al.  Smoking, Body Mass, and Hot Flashes in Midlife Women , 2003, Obstetrics and gynecology.

[19]  R. Wild.  Long-term health consequences of PCOS. , 2002, Human reproduction update.

[20]  J. Grisso,et al.  Sleep Quality, Estradiol Levels, and Behavioral Factors in Late Reproductive Age Women , 2001, Obstetrics and gynecology.

[21]  S. Crawford,et al.  Longitudinal study of hormone levels and depression among women transitioning through menopause , 2001, Climacteric : the journal of the International Menopause Society.

[22]  J. Kelsey,et al.  Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. , 2000, American journal of epidemiology.

[23]  H. Burger,et al.  A Prospective Population‐Based Study of Menopausal Symptoms , 2000, Obstetrics and gynecology.

[24]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[25]  J. Zborowski,et al.  Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome , 2000 .

[26]  E. Diamanti-Kandarakis,et al.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.

[27]  R. Legro,et al.  Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries. , 1999, Molecular endocrinology.

[28]  J. Flaws,et al.  Predictors of menopausal hot flashes. , 1998, Journal of women's health.

[29]  T. Key,et al.  Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. , 1998, The Journal of clinical endocrinology and metabolism.

[30]  R. Hardy,et al.  Women's health in midlife: the influence of the menopause, social factors and health in earlier life , 1997, British journal of obstetrics and gynaecology.

[31]  D. Schoenfeld,et al.  Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[32]  G. Kaltsas,et al.  Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. , 1995, Human reproduction.

[33]  B. Hulka,et al.  Risk Factors for Menopausal Hot Flashes , 1994, Obstetrics and gynecology.

[34]  W. Everaerd,et al.  Impact of climacteric on well-being. A survey based on 5213 women 39 to 60 years old. , 1993, American journal of obstetrics and gynecology.

[35]  B. Scoccia,et al.  Pathological hyperprolactinemia suppresses hot flashes in menopausal women. , 1988, The Journal of clinical endocrinology and metabolism.

[36]  S. Yen,et al.  Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. , 1975, American journal of obstetrics and gynecology.

[37]  D. Ferriman,et al.  Clinical assessment of body hair growth in women. , 1961, The Journal of clinical endocrinology and metabolism.

[38]  J. Schoemaker,et al.  Women with polycystic ovary syndrome gain regular menstrual cycles when ageing , 2000 .

[39]  S. Crawford,et al.  Psychosocial, behavioral, and health factors related to menopause symptomatology. , 1997, Women's health.